Harbour Investments’s Aethlon Medical AEMD Stock Holding History

Harbour Investments’s Portfolio AEMD Stock Details AEMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-1	Closed	-$4K	–	2621
2021 Q3	$4K	Hold	1	–	–	﹤0.01%	3050
2021 Q2	$5K	Buy	+1	New	+$2.3K	﹤0.01%	3023

Other funds holding AEMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Harbour Investments's AEMD Position: Q4 2021 in Review

Harbour Investments sold out of Aethlon Medical (AEMD) in Q4 2021, closing a stake of 1 share — an estimated $4K sold.

Harbour Investments first reported a position in AEMD in Q2 2021 and held it in 2 quarters. The position peaked at $5K in Q2 2021. 24 funds tracked by Wall St. Rank hold AEMD as of Q4 2021.

Harbour Investments reported no remaining Aethlon Medical position as of Q4 2021 after selling out during the quarter.
Harbour Investments sold 1 Aethlon Medical share in Q4 2021, an estimated $4K.
Harbour Investments first reported a position in Aethlon Medical in Q2 2021 and held it in 2 quarters.
Harbour Investments's Aethlon Medical position peaked at $5K in Q2 2021.
24 funds tracked by Wall St. Rank held Aethlon Medical as of Q4 2021.

Based on Harbour Investments's 13F filing for Q4 2021, filed 16 Feb 2022.